Providing a fresh approach to POCT with up to 38 LFD-style tests giving quantitative lab-comparable results when used with any one of our three analyser devices
We are pleased to announce that Helen Dent is our new interim CEO.
Helen has worked as our COO for the past three and a half years, and has over 20 years of industry experience. We look forward to working with Helen and our members to lead BIVDA’s work in the future!
#BIVDA
We would like to thank everyone who attended BIVDA's parliamentary reception in the House of Commons yesterday.
The event was an excellent showcase of the scale of UK IVD innovation and demonstrated the great strength of our industry.
Thank you for hosting @maggie_erewash!
Our CEO, Adam Martin's opinion article has now been published in the March issue of IPC Update, discussing how #POCT has a role to play in reducing NHS Winter Pressures: https://t.co/WbvI7BzOmd
#NHS#future#IVD#rapidtesting#healthcare
One of our team, @WThompson, attended the 'POCT: The Power to Disrupt 2023' event hosted by @TonyCambridgeUK yesterday which included an excellent presentation by @GemmaGash1 about @FrimleyHealth 's Virtual Frailty Ward. A timely reminder of the space for #POCT in Virtual Wards!
We are delighted to be partnering with MHRA to support development of an IVD Regulatory Roadmap on 10 February. This is a critical piece of work & we will be sharing a summary of the day after the event.
A huge ‘thank you’ to one of our sponsors @PremaLabs for supporting #GIANT2022
PremaLabs Diagnostics specialises in easy-to-use Point of Care Test (POCT) solutions that give quality results, with demonstrable efficiencies, and return-on-investment.
👉https://t.co/1QOaVAWgqJ
We're proud to announce @premalabs as a new sponsor of the #GIANT2022
PremaLabs Diagnostics specialises in easy-to-use Point of Care Test (POCT) solutions that give quality results, with demonstrable efficiencies, and return-on-investment.
Register now:
https://t.co/1sK9lPotdu
Interesting recent paper - evidence that serum C-reactive protein is an excellent biomarker of cardiovascular disease and strong predictor of adverse cardiovascular events. Infographic summary below. Full article here: https://t.co/PJYRLuOQil
#poct#crp#ivd#PremaLabs#cvd